Core Concepts
Screening for cognitive impairment is crucial for stroke survivors to improve outcomes and quality of life.
Abstract
The American Heart Association (AHA) emphasizes the importance of screening for cognitive impairment in stroke survivors. The scientific statement focuses on the prevalence, diagnosis, and management of post-stroke cognitive impairment (PSCI). Key points include:
PSCI affects up to 60% of stroke survivors in the first year.
Cognitive recovery is most likely within the first 6 months after a stroke.
Up to 1 in 3 stroke survivors may develop dementia within 5 years.
Cognitive screening tests like the Mini Mental State Examination are commonly used.
Multidisciplinary care involving various specialists is essential for holistic stroke survivor care.
Prevention of recurrent strokes is crucial to reduce the risk of cognitive impairment and dementia.
Research is needed to develop effective treatments for post-stroke cognitive impairment.
Stats
PSCI occurs in up to 60% of stroke survivors in the first year.
Up to 1 in 3 stroke survivors may develop dementia within 5 years.
Recurrent stroke is strongly associated with cognitive impairment and dementia.
Quotes
"It is important to screen stroke survivors for cognitive impairment as well as for associated comorbidities such as mood and sleep disorders." - Nada El Husseini